drugset / Trial / NCT07472790
A Study on the Novel Oncolytic Virus Combined With PD-1 Inhibitor in the Treatment of Recurrent High-grade Glioma
NaSingle-groupOpen-labelTreatment
Summary
A single-arm clinical study on the efficacy and safety of the novel oncolytic virus Ad-TD-nsIL12 combined with PD-1 inhibitors in the treatment of recurrent high-grade glioma
Timeline
- Start
- 2026-07-31
- Primary completion
- 2028-04-30
- Completion
- 2028-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad-TD-nsIL12 | Unknown | 1e+10 unknown | Other |